Back

Levosimendan in outpatients with Advanced heart failure and severe KidnEy disease: the out-LAKE registry

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (1) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giuseppe Uccello

Alessandro Manzoni Hospital, Lecco (Italy)

5 More presentations in this session

Presentation thumbnail
Clinical and safety outcomes of a pharmacist-led medication therapy management clinic (MTM) for heart failure patients in a tertiary hospital in Singapore
Doctor W. Lin (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Guideline-directed medical therapy optimization among multi-ethnic groups of heart failure with reduced ejection fraction patients
Ms C. Chua (Kuching, MY)
Abstract Slides Video
Presentation thumbnail
Trends in angiotensin receptor/neprilysin inhibitor (ARNI) prescribing across multi-Centre, multi-ethnic heart failure population
Ms C. Chua (Kuching, MY)
Abstract Slides Video
Presentation thumbnail
Trend of echocardiographic parameters, ventricular-arterial coupling, and biomarkers in advanced heart failure patients undergoing intermittent home-based levosimendan infusion
Doctor R. Pugliese (Brindisi, IT)
Abstract Slides Video
Presentation thumbnail
Intermittent levosimendan in advanced palliative heart failure improves quality of life and reduces heart failure decompensations: a single center-experience
Doctor J. Quintal (Setubal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Reducing the burden of advanced heart failure: a clinical and economical analysis of an intermittent Levosimendan programme
thumbnail
Congress Presentation
Trend of echocardiographic parameters, ventricular-arterial coupling, and biomarkers in advanced heart failure patients undergoing intermittent home-based levosimendan infusion
thumbnail
Congress Presentation
Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources